Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis? : Current Opinion in Rheumatology

Secondary Logo

Journal Logo

SPONDYLOARTHRITIS INCLUDING PSORIATIC ARTHRITIS: Edited by Joerg Ermann

Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?

Eshed, Iris; Diekhoff, Torsten; Hermann, Kay Geert A.

Author Information
Current Opinion in Rheumatology 35(4):p 219-225, July 2023. | DOI: 10.1097/BOR.0000000000000925

Abstract

Purpose of review 

Pelvic radiography in which structural lesions characteristic of sacroiliitis can be detected, is recommended as the first imaging modality when axial spondyloarthritis (axSpA) is suspected clinically. However, cross-sectional modalities like computed tomography (CT) and magnetic resonance imaging (MRI) are superior to radiographs for diagnosing sacroiliitis. Thus, we currently debate the role of radiography as first imaging modality in the diagnostic workup of axSpA.

Recent findings 

Diagnosing sacroiliitis on pelvic radiographs is challenging with large interobserver and intraobserver variation. Low-dose CT (ldCT) of the sacroiliac joints (SIJs) was proved to be more sensitive and reliable than radiographs with comparable ionizing radiation exposure. MRI is the preferred modality for detecting early SIJ inflammation, well before structural lesions evolve. New, promising MRI sequences sensitive to cortical bone improve erosion detection, making MRI a one-stop shop for the diagnosis of sacroiliitis.

Summary 

Given the debatable additive value of pelvic radiographs for the detection of sacroiliitis, and the presence of excellent alternatives for imaging the bony cortex of the SIJs such as ldCT and MRI with state-of-the-art sequences sensitive to cortical bone, it is high time to discuss the use of these more accurate modalities instead of radiographs.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid